 CV effect toler safeti studi twenti hyperprolactinem women median prolactin prl mu/l mu/l bromocriptin prospect studi month new nonergot long-act dopamin agonist CV treatment normal prl patient daili dose mg drug patient dose mg mg prl studi menstrual function amenorrh patient galactorrhea present patient patient pregnant birth healthi children conclus CV effect daili dose good toler safe valuabl altern dopamin agonist drug use today